|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,435.50 INR | -0.31% |
|
+0.81% | -1.43% |
| Market Cap | 413B 4.33B 3.78B 3.49B 3.22B 6.12B 6.22B 41.7B 16.38B 203B 16.24B 15.89B 699B | P/E 2027 * |
35.8x | P/E 2028 * | 31.5x |
|---|---|---|---|---|---|
| Enterprise Value | 413B 4.33B 3.78B 3.49B 3.22B 6.12B 6.22B 41.7B 16.38B 203B 16.24B 15.89B 699B | EV / Sales 2027 * |
9.84x | EV / Sales 2028 * | 8.88x |
| Free-Float |
24.36% | Yield 2027 * |
1.21% | Yield 2028 * | 1.21% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -0.31% | ||
| 1 week | +0.81% | ||
| Current month | -0.63% | ||
| 1 month | +10.98% | ||
| 3 months | +3.19% | ||
| 6 months | +2.57% | ||
| Current year | -1.43% |
| 1 week | 2,370.65 |  | 2,460 |
| 1 month | 2,088 | | 2,508.35 |
| Current year | 2,088 | | 2,715.15 |
| 1 year | 2,088 | | 3,266.95 |
| 3 years | 1,376.5 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 2022-11-30 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 2026-03-31 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 2017-04-06 |
Renu Sud Karnad
CHM | Chairman | 73 | 2019-03-31 |
| Director/Board Member | 59 | 2020-05-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | +0.81% | -26.20% | +74.04% | 4.34B | |
| -2.76% | -1.46% | +49.56% | +160.94% | 1,085B | |
| -0.91% | -1.23% | +62.44% | +60.59% | 624B | |
| -1.44% | -3.46% | +26.13% | +82.88% | 442B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 332B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 277B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 217B | |
| -0.44% | -1.15% | +20.59% | +61.18% | 196B | |
| -3.61% | +0.46% | +13.68% | +72.03% | 167B | |
| Average | -1.30% | -1.57% | +19.10% | +57.02% | 362.63B | |
| Weighted average by Cap. | -1.64% | -1.06% | +34.83% | +81.00% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.94B 440M 385M 355M 328M 622M 632M 4.24B 1.66B 20.66B 1.65B 1.62B 71.03B | 46.45B 487M 426M 393M 363M 689M 700M 4.7B 1.84B 22.88B 1.83B 1.79B 78.67B |
| Net income | 11.51B 121M 106M 97.41M 89.97M 171M 174M 1.16B 457M 5.67B 453M 443M 19.5B | 12.87B 135M 118M 109M 101M 191M 194M 1.3B 511M 6.34B 507M 496M 21.8B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | ₹2,435.50 | -0.31% | 2,897 |
| 26-07-09 | ₹2,443.10 | +1.38% | 3,459 |
| 26-07-08 | ₹2,409.90 | +0.29% | 6,361 |
| 26-07-07 | ₹2,402.90 | +0.10% | 4,333 |
| 26-07-06 | ₹2,400.60 | +0.33% | 183,948 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
